FEATURES Filter By:
01 February 2012
Last year saw the first in a new class of product for treating hepatitis C infections reach the market. Vertex Pharmaceuticals’ Incivek (telaprevir) and Merck & Co’s Victrelis (boceprevir) are protease inhibitors (to be more accurate, they inhibit viral NS3 serine protease, an enzyme required for ...
26 January 2012
Incoming Thai Prime Minister Yingluck Shinawatra gained much support from the local pharma community last year on announcing a series of health policy goals. She won the mandate to reform the healthcare and other sectors of the Thai economy after her PTP party’s landslide victory in the July 2011 ...
05 January 2012
Clinical study design teams have historically been cost conscious, but not necessarily cost averse. The cost conscious clinical team will forecast study costs and have a keen awareness that choices made in study design will have monetary consequences for the study budget. The cost averse clinical ...
 
MOST MENTIONED
COMPANY/ORGANISATION
CONDITION
GEOGRAPHY
DRUG
EVENTS
04 March 2012
The Marriott World Center, Orlando, Florida
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36